Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Clinical trial NCT00410423 · COMPLETED
Trial details
- NCT number
- NCT00410423
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.